The melatonin-microbiome axis: a new frontier in gut health for the immunomodulatory, antioxidant and anti-inflammatory properties
Inflammopharmacology · 2026-01 · 34 (1) · 227-242
DOI: 10.1007/s10787-025-02005-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Inflammopharmacology, online erschienen am 17.12.2025. Verfasst von Priyanka Gupta und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Sanaka Educational Trust's Group of Institutions, Durgapur, West Bengal, 713212, India. Hauptthemen laut MEDLINE: Melatonin, Gastrointestinal Microbiome, Antioxidants, Anti-Inflammatory Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 127 Literaturangaben. Gefördert von: Deanship of Scientific Research, King Khalid University.
Abstract (Originalsprache)
Melatonin, primarily produced by the pineal gland, is also synthesized in significant amounts within the gastrointestinal (GI) tract, where its presence surpasses that in the brain. While the pineal gland secretes melatonin to regulate circadian rhythms and promote sleep, gut-derived melatonin plays a crucial role in regulating motility, protecting the mucosa from oxidative stress, and modulating immune function. The interaction between melatonin and gut microbiota is gaining significant attention, as melatonin can influence specific gut microbes and functions, potentially altering the intestinal microbiota, which is essential for maintaining overall health. This review explores the bidirectional relationship between melatonin and gut microbiota, highlighting its influence on microbial composition, intestinal barrier function, microbial metabolism, and immune modulation. Additionally, melatonin indirectly affects the gut microbiota through circadian regulation, further reinforcing its critical role in gut homeostasis. The presence of melatonin receptors in the gut and its interaction with microbial biofilms underline its importance in maintaining a balanced gut environment. Given these multifaceted roles, melatonin emerges as a promising therapeutic candidate for managing gut-related disorders such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and metabolic dysregulation. Despite its promising therapeutic potential, several aspects of melatonin-gut microbiome interactions remain unexplored, necessitating further research into its molecular mechanisms and clinical applications. This review provides an in-depth exploration of melatonin's role in gut microbiome regulation, its therapeutic implications, and future research directions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Sanaka Educational Trust's Group of Institutions, Durgapur, West Bengal, 713212, India.
- Department of Pharmaceutical Technology, Bharat Technology, Uluberia, 711316, West Bengal, India.
- Department of Pharmaceutical Technology, Bharat Technology, Uluberia, 711316, West Bengal, India. ashiquesumel007@gmail.com.
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144411, India. ashiquesumel007@gmail.com.
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144411, India.
- Department of Pharmaceutical Chemistry, College of Pharmacy, King Khalid University, 62529, Abha, Saudi Arabia.
Förderung
- Deanship of Scientific Research, King Khalid University
Zitieren
APA
Gupta, P., Debnath, B., Ashique, S., Ramzan, M., Yasmin, S., Shorog, E., Mantry, S., Tariq, M., Sridhar, S. B., Panigrahy, U. P., Sharma, H., Iqbal, A., Prabhakar, P. K., & Ansari, M. Y. (2026). The melatonin-microbiome axis: a new frontier in gut health for the immunomodulatory, antioxidant and anti-inflammatory properties. Inflammopharmacology, 34(1), 227-242. https://doi.org/10.1007/s10787-025-02005-4
Vancouver
Gupta P, Debnath B, Ashique S, Ramzan M, Yasmin S, Shorog E, et al. The melatonin-microbiome axis: a new frontier in gut health for the immunomodulatory, antioxidant and anti-inflammatory properties. Inflammopharmacology. 2026;34(1):227-242. doi:10.1007/s10787-025-02005-4
BibTeX
@article{Gupta2026,
author = {Gupta, Priyanka and Debnath, Biplab and Ashique, Sumel and Ramzan, Mohhammad and Yasmin, Sabina and Shorog, Eman and Mantry, Shubhrajit and Tariq, Mohd and Sridhar, Sathvik Belagodu and Panigrahy, Uttam Prasad and Sharma, Himanshu and Iqbal, Asif and Prabhakar, Pranav Kumar and Ansari, Md Yousuf},
title = {The melatonin-microbiome axis: a new frontier in gut health for the immunomodulatory, antioxidant and anti-inflammatory properties},
journal = {Inflammopharmacology},
year = {2026},
volume = {34},
number = {1},
pages = {227--242},
doi = {10.1007/s10787-025-02005-4}
}
EUVIMED